In a report released today, Rupesh Parikh from Oppenheimer maintained a Hold rating on OrganiGram Holdings (OGI). The company’s shares closed last Monday at $1.81, close to its 52-week low of $1.41.
According to TipRanks.com, Parikh is a 5-star analyst with an average return of 14.0% and a 60.0% success rate. Parikh covers the Services sector, focusing on stocks such as United Natural Foods, Sprouts Farmers, and Dollar General.
OrganiGram Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $3.52.
See today’s analyst top recommended stocks >>
Based on OrganiGram Holdings’ latest earnings release for the quarter ending November 30, the company reported a quarterly revenue of $25.15 million and GAAP net loss of $863K. In comparison, last year the company earned revenue of $12.44 million and had a net profit of $29.48 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
Read More on OGI:
